- Home
- EPIX vs DOMH Comparison
EPIX vs DOMH Comparison
Compare EPIX & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- DOMH
- Stock Information
- Founded
- EPIX 2009
- DOMH 1967
- Country
- EPIX Canada
- DOMH United States
- Employees
- EPIX N/A
- DOMH N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- EPIX Health Care
- DOMH Health Care
- Exchange
- EPIX Nasdaq
- DOMH Nasdaq
- Market Cap
- EPIX 75.9M
- DOMH 74.7M
- IPO Year
- EPIX N/A
- DOMH N/A
- Fundamental
- Price
- EPIX $1.93
- DOMH $6.40
- Analyst Decision
- EPIX Hold
- DOMH
- Analyst Count
- EPIX 3
- DOMH 0
- Target Price
- EPIX $2.00
- DOMH N/A
- AVG Volume (30 Days)
- EPIX 304.7K
- DOMH 358.3K
- Earning Date
- EPIX 08-13-2025
- DOMH 08-11-2025
- Dividend Yield
- EPIX N/A
- DOMH 5.00%
- EPS Growth
- EPIX N/A
- DOMH N/A
- EPS
- EPIX N/A
- DOMH N/A
- Revenue
- EPIX N/A
- DOMH $52,811,000.00
- Revenue This Year
- EPIX N/A
- DOMH N/A
- Revenue Next Year
- EPIX N/A
- DOMH N/A
- P/E Ratio
- EPIX N/A
- DOMH N/A
- Revenue Growth
- EPIX N/A
- DOMH 455.38
- 52 Week Low
- EPIX $1.40
- DOMH $0.83
- 52 Week High
- EPIX $7.88
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- EPIX 71.19
- DOMH 61.78
- Support Level
- EPIX $1.90
- DOMH $5.32
- Resistance Level
- EPIX $1.93
- DOMH $7.60
- Average True Range (ATR)
- EPIX 0.01
- DOMH 0.59
- MACD
- EPIX -0.00
- DOMH 0.15
- Stochastic Oscillator
- EPIX 100.00
- DOMH 63.53
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.